Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis
BackgroundThe clinical benefits of high-dose intravenous immunoglobulin (IVIg) in treating COVID-19 remained controversial.MethodsWe systematically searched databases up to February 17, 2022, for studies examining the efficacy of IVIg compared to routine care. Meta-analyses were conducted using the...
Main Authors: | Xiaosheng Liu, Yuelun Zhang, Lianfeng Lu, Xiaodi Li, Yuanni Wu, Yang Yang, Taisheng Li, Wei Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1116738/full |
Similar Items
-
Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia
by: Ling Lin, et al.
Published: (2020-01-01) -
CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy
by: Xiaodi Li, et al.
Published: (2023-05-01) -
Clinical and immunological characteristics of HIV/syphilis co-infected patients following long-term antiretroviral treatment
by: Yuanni Wu, et al.
Published: (2024-01-01) -
Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy
by: Lianfeng Lu, et al.
Published: (2023-09-01) -
Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol
by: Xiaodi Li, et al.
Published: (2022-12-01)